Malignant neoplasms as a nosological cause of primary disability in the Russian Federation during the COVID-19 pandemic

Abstract

BACKGROUND: In cases of health disorders secondary to malignant neoplasms that lead to social restrictions and the need for social protection measures, including rehabilitation, disability is established. This is the most important health indicator of the population. Coronavirus disease 2019 (COVID-19) has significantly affected the management of patients with malignant diseases, and a more severe course of COVID-19 commonly occurs in older age groups.

AIM: This study aimed to analyze the dynamics and structure of primary disability caused by malignant neoplasms in the adult population in the Russian Federation.

MATERIALS AND METHODS: The study object was a cohort with newly recognized disability caused by malignant neoplasms in the Russian Federation (by applying to the Bureau of Medical and Social Expertise). The main outcome was the occurrence of primary disability during the study period. Three age groups of the adult population (young, middle, and old) were analyzed. The study was conducted in 2010–2020. Research methods included documentary, data copying, and statistical and graphics analysis.

RESULTS: The dynamics of cancer-related primary disability in the Russian Federation was characterized by an annual increase in the number of people with disability from 180.2 thousand in 2010 to 214.6–222.2 thousand in 2017–2019; however, this number decreased to 196.5 thousand in 2020. The number of older people with primary disability was the highest, followed by middle-aged people with primary disability, and no significant change was found in the number of young people with primary disability. The proportion of people with secondary disability decreased, and those with tertiary disability increased, with a negative trend in the growth of the proportion of people with primary disability in 2020.

CONCLUSIONS: The incidence of disability caused by malignant neoplasms may not reflect the proportion of populations with persistent health disorders because residents were unable to present for medical consultations due to the restrictions caused by the spread of a new coronavirus infection. The scale and structure of primary disabilities caused by cancer become the scientific and practical basis for determining directions for developing healthcare and social protection services.

Keywords

malignant neoplasms / disability / age / group / rate / Russian Federation / peculiarities / COVID-19 epidemic

References

[1] Puzin SN, Shurgaya MA, Achkasov EE, et al. Medico-social aspects of repeated disability of the adult population due to malignant neoplasms in the Russian Federation. Problems Social Hygiene, Healthcare History Med. 2019;27(1):18–22. (In Russ).

[2] Пузин С.Н., Шургая М.А., Ачкасов Е.Е., и др. Медико-социальные аспекты повторной инвалидизации взрослого населения вследствие злокачественных новообразований в Российской Федерации // Проблемы социальной гигиены, здравоохранения и истории медицины. 2019. Т. 27, № 1. С. 18–22.

[3] Kutyrev VV, Popova AYu, Smolensky VYu, et al. Epidemiological features of the new coronavirus infection (COVID-19). Message 1: Models for the implementation of preventive and anti-epidemic measures. Problems Particularly Dangerous Inf. 2020;(1):6–13. (In Russ). doi: 10.21055/0370-1069-2020-1-6-13

[4] Кутырев В.В., Попова А.Ю., Смоленский В.Ю., и др. Эпидемиологические особенности новой коронавирусной инфекции (COVID-19). Сообщение 1: Модели реализации профилактических и противоэпидемических мероприятий // Проблемы особо опасных инфекций. 2020. № 1. С. 6–13. doi: 10.21055/0370-1069-2020-1-6-13

[5] Nikiforov VV, Suranova TG, Chernobrovkina TYa, et al. New coronavirus infection (COVID-19): clinical and epidemiological aspects. Arch Internal Med. 2020;10(2):87–93. (In Russ). doi: 10.20514/2226-6704-2020-10-2-87-93

[6] Никифоров В.В., Суранова Т.Г., Чернобровкина Т.Я., и др. Новая коронавирусная инфекция (COVID-19): клинико-эпидемиологические аспекты // Архив внутренней медицины. 2020. Т. 10, № 2. С. 87–93. doi: 10.20514/2226-6704-2020-10-2-87-93

[7] Pshenichnaya NYu, Lizenfeld IA, Zhuravlev GYu, et al. The epidemic process of COVID-19 in the Russian Federation: interim results. Message 1. Infectious diseases. 2020;18(3):7–14. (In Russ). doi: 10.20953/1729-9225-2020-3-7-14

[8] Пшеничная Н.Ю., Лизинфельд И.А., Журавлёв Г.Ю., и др. Эпидемический процесс COVID-19 в Российской Федерации: промежуточные итоги. Сообщение 1 // Инфекционные болезни. 2020. Т. 18, № 3. С. 7–14. doi: 10.20953/1729-9225-2020-3-7-14

[9] Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145–151. [In Chinese]. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003

[10] Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. [In Chinese] // Zhonghua Liu Xing Bing Xue Za Zhi. 2020. Vol. 41, N 2. P. 145–151. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003

[11] Caruso D, Zerunian M, Polici M, et al. Chest CT Features of COVID-19 in Rome, Italy. Radiology. 2020;296(2):79–85. doi: 10.1148/radiol.2020201237

[12] Caruso D., Zerunian M., Polici M., et al. Chest CT Features of COVID-19 in Rome, Italy // Radiology. 2020. Vol. 296, N 2. P. 79–85. doi: 10.1148/radiol.2020201237

[13] Adam D. 15 million people have died in the pandemic, WHO says. Nature. 2022;605(7909):206. doi: 10.1038/d41586-022-01245-6

[14] Adam D. 15 million people have died in the pandemic, WHO says // Nature. 2022. Vol. 605, N 7909. Р. 206. doi: 10.1038/d41586-022-01245-6

[15] The main indicators of primary disability of the adult population of the Russian Federation. Statistical collections. Moscow; 2011–2019. (In Russ).

[16] Основные показатели первичной инвалидности взрослого населения Российской Федерации. Статистические сборники. Москва, 2011–2019.

[17] Yuldasheva NO, Kunafina RI, Sakaeva DD, et al. Analysis of the incidence of a new coronavirus infection in oncological patients on the example of the oncological department of antitumor drug therapy of the FSBI BSMU of the Ministry of Health of the Russian Federation. Pharmateca. 2020;27(11):52–54. (In Russ). doi: 10.18565/pharmateca.2020.11.52-54

[18] Юлдашева Н.О., Кунафина Р.И., Сакаева Д.Д., и др. Анализ заболеваемости новой коронавирусной инфекцией у онкологических пациентов на примере онкологического отделения противоопухолевой лекарственной терапии ФГБУ БГМУ МЗ РФ // Фарматека. 2020. Т. 27, № 11. С. 52–54. doi: 10.18565/pharmateca.2020.11.52-54

[19] Kaprin AD, Fedenko AA, Polyakov AA, Polyakov AP. Strategy of surgical treatment of cancer patients in the conditions of the COVID-19 pandemic. Surgery. Magazine named after N.I. Pirogov. 2020;(12):5–15. (In Russ). doi: 10.17116/hirurgia20201215

[20] Каприн А.Д., Феденко А.А., Поляков А.А., Поляков А.П. Стратегия хирургического лечения онкологических больных в условиях пандемии COVID-19 // Хирургия. Журнал имени Н.И. Пирогова. 2020. № 12. С. 5–15. doi: 10.17116/hirurgia20201215

[21] Sharova OM, Grebenkina EV, Gamayunov SV. The impact of the COVID-19 pandemic on the main indicators of the state of the oncological service. Oncology. Journal named after P.A. Herzen. 2022;11(1):34–39. (In Russ). doi: 10.17116/onkolog20221101134

[22] Шадрова О.М., Гребенкина Е.В., Гамаюнов С.В. Влияние пандемии COVID-19 на основные показатели состояния онкологической службы // Онкология. Журнал имени П.А. Герцена. 2022. Т. 11, № 1. С. 34–39. doi: 10.17116/onkolog20221101134

Funding

Федеральный научно-клинический центр реанимации и реабилитологии, Лыткино, Московская область, Российская Федерация 2 Российская медицинская академия непрерывного профессионального образования, Москва, Российская ФедерацияFederal Scientific and Clinical Center of Resuscitation and Rehabilitation, Lytkino, Moscow region, Russian Federation 2 Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation

RIGHTS & PERMISSIONS

Eco-Vector